Dr. Mojdeh purchased a total of 54,000 shares of Unilife's common stock at an average price of $4.61 per share, with an approximate value of $248,652. This open market purchase by Dr. Mojdeh follows similar activity undertaken by Unilife CEO Alan Shortall, as reported on March 16, 2011.
Dr. Mojdeh stated, "Since joining Unilife just six weeks ago, I have grown increasingly impressed by the Company's proprietary technologies, operational capabilities and commercial position. With initial production of the Unifill syringe about to commence, we are now entering an important period of business development. As we remain on schedule to fill our initial orders for the Unifill syringe starting in June 2011, and are continuing to accelerate discussions with a number of interested pharmaceutical companies, I have decided to make an open market purchase of Unilife shares at this time."
Sign them all up Dr. Mojdeh! Volume increasing on NASDAQ. 80k through in the first hour of trade up 6%.
UNS Price at posting:
84.5¢ Sentiment: LT Buy Disclosure: Held
